The role of material deprivations in determining ART adherence: Evidence from a conjoint analysis among HIV-positive adults in Uganda.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 26 12 2021
accepted: 30 06 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Despite sustained global scale-up of antiretroviral therapy (ART), adherence to ART remains low. Less than half of those in HIV care in Uganda achieve 85% adherence to their ART medication required for clinically meaningful viral suppression, leaving them at higher risk of transmission. Key barriers to ART adherence include poverty-related structural barriers that are inter-connected and occur simultaneously, making it challenging to examine and disentangle them empirically and in turn design effective interventions. Many people living with HIV (PLWH) make tradeoffs between these various barriers (e.g., between expenses for food or transportation) and these can influence long-term health behavior such as adherence to ART. To be able to estimate the distinct influence of key structural barriers related to poverty, we administered a conjoint analysis (CA) to 320 HIV-positive adults currently taking ART at an urban clinic in Uganda between July 2019 and September 2020. We varied the levels of four poverty-related attributes (food security, sleep deprivation, monthly income, and physical pain) that occur simultaneously and asked respondents how they would adhere to their medication under different combinations of attribute levels. This allows us to disentangle the effect of each attribute from one another and to assess their relative importance. We used regression analysis to estimate the effects of each attribute level and found that food security impacts expected adherence the most (treatment effect = 1.3; 95% CI 1.11-1.49, p<0.001), followed by income (treatment effect = 0.99; 95% CI 0.88-1.10, p<0.001. Sleep and pain also impact adherence, although by a smaller magnitude. Sub-group analyses conducted via regression analysis examine heterogeneity in results and suggest that the effects of material deprivations on expected adherence are greater among those with high levels of existing food insecurity. Results from this CA indicate that external factors inherent in the lives of the poor and unrelated to direct ART access can be important barriers to ART adherence. This study applies a CA (typically administered in marketing applications) among PLWH to better understand individual-level perceptions relating to poverty that often occur simultaneously. Policy interventions should address food insecurity and income to improve adherence among HIV-positive adults.

Identifiants

pubmed: 36962701
doi: 10.1371/journal.pgph.0000374
pii: PGPH-D-21-01183
pmc: PMC10022174
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000374

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH110350
Pays : United States

Informations de copyright

Copyright: © 2022 Saya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2019 Jan 10;14(1):e0210408
pubmed: 30629648
Pain Manag. 2020 Jul;10(4):253-260
pubmed: 32484065
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83
pubmed: 26575631
Clin Infect Dis. 2015 Nov 1;61(9):1453-61
pubmed: 26157050
PLoS One. 2013 Dec 18;8(12):e81355
pubmed: 24367482
AIDS Behav. 2014 Oct;18 Suppl 5:S505-15
pubmed: 23842717
JAMA. 2000 Mar 8;283(10):1329-34
pubmed: 10714734
Trials. 2020 Jan 3;21(1):9
pubmed: 31900193
Transl Behav Med. 2015 Dec;5(4):470-82
pubmed: 26622919
Q J Econ. 2021 Apr 08;136(3):1887-1941
pubmed: 34220361
AIDS. 2018 Sep 10;32(14):2023-2031
pubmed: 29847330
J Int AIDS Soc. 2017 Mar 22;20(1):21371
pubmed: 28630651
Afr J AIDS Res. 2019 Dec;18(4):332-340
pubmed: 31779576
Health Policy Plan. 2009 Mar;24(2):151-8
pubmed: 19112071
PLoS One. 2019 Jan 7;14(1):e0209903
pubmed: 30615692
PLoS Med. 2016 Nov 29;13(11):e1002183
pubmed: 27898679
PLoS One. 2020 Jun 4;15(6):e0233849
pubmed: 32497153
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
AIDS Behav. 2011 Oct;15(7):1381-96
pubmed: 21468660
AIDS Res Ther. 2020 Jun 8;17(1):30
pubmed: 32513192
Brain Behav Immun. 2018 Mar;69:548-555
pubmed: 29452219
Med Decis Making. 2018 Jan;38(1):120-133
pubmed: 28863752
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
J Int AIDS Soc. 2014 Feb 18;17:18719
pubmed: 24560338
AIDS Behav. 2010 Aug;14(4):778-84
pubmed: 19283464
PLoS One. 2019 Oct 30;14(10):e0224566
pubmed: 31665153
Value Health. 2013 Jan-Feb;16(1):3-13
pubmed: 23337210
AIDS Care. 2018;30(sup3):85-98
pubmed: 29985055
Health Econ. 2012 Feb;21(2):145-72
pubmed: 22223558
BMC Public Health. 2018 Oct 4;18(1):1158
pubmed: 30286746
AIDS Care. 2021 Sep;33(9):1196-1200
pubmed: 32482093
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Clin Infect Dis. 2001 Oct 15;33(8):1417-23
pubmed: 11550118
AIDS. 2019 Mar 1;33(3):515-524
pubmed: 30325776
AIDS Behav. 2015 Nov;19(11):2069-75
pubmed: 25987190
BMC Public Health. 2010 Aug 11;10:475
pubmed: 20701789
AIDS. 2018 Sep 10;32(14):2043-2049
pubmed: 29894386
Science. 2014 May 23;344(6186):862-7
pubmed: 24855262
Curr Dev Nutr. 2018 Jul 20;2(9):nzy062
pubmed: 30191202
AIDS. 2005 Aug 12;19(12):1243-9
pubmed: 16052078
AIDS Patient Care STDS. 2011 Sep;25(9):517-24
pubmed: 21770763
AIDS. 2012 Nov 28;26(18):2375-81
pubmed: 22948270
Science. 2013 Aug 30;341(6149):976-80
pubmed: 23990553
AIDS Behav. 2015 Aug;19(8):1510-26
pubmed: 25096896
AIDS Behav. 2017 Mar;21(3):754-765
pubmed: 27837425
Neurol Res Int. 2014;2014:298703
pubmed: 24876959
J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):e15-8
pubmed: 24047975
AIDS Behav. 2013 Jan;17(1):307-18
pubmed: 23108721
AIDS Patient Care STDS. 2013 Oct;27(10):544-52
pubmed: 24032625
Curr Psychiatry Rep. 2015 Jan;17(1):530
pubmed: 25413636
PLoS One. 2010 Apr 28;5(4):e10340
pubmed: 20442769
AIDS. 2017 Mar 27;31(6):815-825
pubmed: 28107221
JAMA. 2006 Aug 9;296(6):679-90
pubmed: 16896111

Auteurs

Uzaib Saya (U)

Pardee RAND Graduate School, Santa Monica, California, United States of America.
RAND Corporation, Santa Monica, California, United States of America.

Zachary Wagner (Z)

Pardee RAND Graduate School, Santa Monica, California, United States of America.
RAND Corporation, Santa Monica, California, United States of America.

Barbara Mukasa (B)

Mildmay Uganda, Mildmay Hospital and Institute of Health Sciences, Kampala, Uganda.

Peter Wabukala (P)

Mildmay Uganda, Mildmay Hospital and Institute of Health Sciences, Kampala, Uganda.

Lillian Lunkuse (L)

Mildmay Uganda, Mildmay Hospital and Institute of Health Sciences, Kampala, Uganda.

Sebastian Linnemayr (S)

Pardee RAND Graduate School, Santa Monica, California, United States of America.
RAND Corporation, Santa Monica, California, United States of America.

Classifications MeSH